semaglutide cyanocobalamin injection Troubling Findings in Study of GLP-1 Compounders Semaglutide Cyanocobalamin – Dynamic3 Health

10.16281/j.cnki.jocml.2019.96.008 278 ZhaoL.ZhaoZ.LiuY.SunL

Notably, although there was not a statistically significant increase in biliary disease among GLP-1 receptor agonist users in this study, the FDA 2 added warnings and precautions about acute cholecystitis and biliary disease to the label in late 2022 based on data from placebo-controlled RCTs as well as other observational data 3

K., Smuder, A

This decreased clinical benefit is likely to result in patients taking compounded GLP-1s discontinuing therapy more quickly than patients using the brand-name drugs

doi:10.1021/bi2003247 Dixon SJ, Patel DN, Welsch M et al (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis

In case of allergy or reaction consult your doctor